About us

CANAAN is a Venture Capital Club created for the development and management of investment processes in businesses, patents and lines of research.

Mission

Investment in R+D+i proyects in health, medicine, biotechnology and environment areas that may be at an adequate development phase to allow either a great revaluation of the investment or a quick access to the market with the resulting social benefit.

Vision

To be an international reference in the investment areas oriented to innovative projects in our field of competence. We offer investments selected with a stringent criterion and with a very high revaluation potential for the investor.

Science to market

Team

Canaan team is composed of technology managers, scientific experts and financial analysts.

Unlike other investment tools, Canaan has a group of scientific experts in each area subject to our investments.

Our managers have an extensive backround regarding management and direction of this type of projects.

We walk with the investors through each and every phase of the project until its access to the market. Every investment must be accompanied by an in-depth knowledge of the area and of the project.

JUAN JOSÉ MONTOYA MIÑANO

Academic training:

  • • Doctor of Medicine and Surgery (UAM).
  • • Master in Business Administration (UAX).
  • • Senior Management Program in Research and Transfer Institutions (IEFE).
  • • Specialist in Physical Education and Sports Medicine (MIR).
Professional experience:
  • • Ex-director of the Foundation for Research (University Alfonso X el Sabio).
  • • Evaluator of scientific projects for the ANEP, ANECA.
  • • Medicine Professor in the Complutense University of Madrid.
  • • He has participated in several research projects and in international scientific publications.
  • • Director Health Area at Recol Networks S.A.
  • • Adviser in Mirnax Biosens, S.L.
  • • Adviser in Isquaemia Biotech, S.L.
  • • Adviser in Canaan Research & Investment, S.L.

PABLO CASTÁN

Academic Training:

  • • Doctor of Molecular Biology (Autónoma University Madrid).
  • • Bachelor in Molecular Medicine (East Anglia University - University of Cambridge School of Medicine).
Professional Experience:
  • • Full profesor of Medical Microbiology (IESE).
  • • Scientific director of Biotools.
  • • Scientific director and founder of 2b Black Bio.
  • • Scientific director and founder of Génolab.
  • • Scientific director of Genotest.
Currently:
  • • Scientific advisor of Epistem.
  • • Lead researcher in ARCIS.

BRUNO BERHEIDE

  • • Director of Development of Polinat.
  • • Ex-Director of the Spanish Bank of Algae. Marine Biotechnology Center.
  • • Project ex-Director in Services Supporting Sciencie Research.
  • • PharmaMar- Zeltia Group- New drug department.

ALBERTO ABÁNADES VELASCO

  • • Teacher in the Nuclear Engineering and Fluid Mechanic (University of País Vasco).
  • • Interim Teacher in the Energic Engineering and Fluid Mechanic department of E.T.S.I. Industriales of the Politécnica University of Madrid.
  • • Teaching and research activity in the Solar Thermal Energy, and in research in technologies of Hydrogen generation.
Previously:
  • • Head of Project of LAESA, Company founded for the development of Amplifier of Energy.

ENRIQUE SAINZ MARTÍNEZ

Previously:

  • • President and co-founder of “Valoralia I+D”, leading company in research and development of cyanobacterias.
  • • CEO of subvenciuris, consultant specialised in aids for R&D companies.
  • • Financial advisor in AXA investment.

WALTER R. VAN ROSMALEN

  • • Member of Board of Terquimsa, Joint venture de CLH and VOPA IntergaS adviser.
Previously:
  • • Member of Board of Repsol Química.
  • • Member del Board of Repsol – General Director of Petrochemicals.

ALFONSO ORTEGA GALLEGO

Previously:

  • • Technological and environmental adviser. He is directly involved in different financial operations in the biotechnology sector.
  • • Wealth Management; size of managed portfolio: 20 millions of euros.

FERNANDO MARTINEZ MORALES

Partner:

  • • Commercial director at Astellas Pharma.
  • • Head of sales in Astrazeneca Pharmaceutical.
  • • Commercial director at Rovi Laboratories.

RAMÓN ARMENGOD CORBELLA

Adviser:

  • • Head of sales Biosurgery in Baxter.
  • • Sales director at Gynea.
  • • Commercial director at Isdin.
  • • Regional director at AstraZeneca.

ISABEL LÓPEZ LEDESMA

Adviser:

  • • Degree in Chemical Sciences.
  • • Master in management for the pharmaceutical industry.
  • • Worked in the commercial department of both companies and banks (consultant / sales manager).

FELIPE MONIS RUIZ

  • • Bachelor in economics and law –ICADE.
  • • 35 years of experience as financial advisor and asset manager.
  • • Private banking advisor at AndBank.
  • • Partner Playbox Multimedia, S.L.
  • • President and CEO of lsquaemia Biotech, S.L.
  • • Adviser of Canaan Research Investmente, S.L.

PEDRO JAÉN OLASOLO

  • • Doctor of Medicine and Surgery of the Complutense University of Madrid.
  • • Specialist in Medical-Surgical Dermatology and Venereology.
  • • Head of the Dermatology Service of the Hospital Ramón y Cajal, Madrid.
  • • President of the Spanish Academy of Dermatology and Venereology.
  • • President of the National Commission of Dermatology of the Ministry Of Health.
  • • Author of more than 150 national and international publications (dermathology area).

JESÚS ESPADA REGALADO

  • • Doctor of Biology of the Autónoma University (Madrid).
  • • Lead researcher of Ramon y Cajal Institute for Health Research (IRYCIS), Foundation for Biomedical Research of the Hospital Ramón y Cajal.
  • • Project: Activation of endogenous production of ROS in tissue for the treatment of burns and wounds, pathologies of the follicle Piloso and development of artificial skin of new generation.
  • • Number of funded research projects in which Attended: 14

ALBERTO ALCÁZAR GONZÁLEZ

  • • Bachelor of Biological Sciences.
  • • Doctor in Biology.
  • • Ramon y Cajal Institute for Health Research (IRYCIS), Foundation for Biomedical Research of the Hospital Ramón y Cajal.
  • • Number of funded research projects in which has participated as Lead Researcher: 8.

JAIME MASJUAN VALLEJO

  • • Neurology (San Pablo CEU University).
  • • Chief of Service of Neurology Hospital Ramon y Cajal. Hospital Complex Ruber Juan Bravo.
  • • Coordinator of the Stroke Unit of the University Hospital Ramón y Cajal of Madrid.
  • • Former Coordinator of the Study Group on Cerebrovascular diseases of the Spanish Society of Neurology.
  • • Researcher in numerous studies in the field of cerebrovascular diseases.
  • • Author of more than 100 publications on stroke.

SUSANA CAMPUZANO RUIZ

  • • Bachelor in chemical sciences.
  • • Researcher in 20 research projects (19 national and 1 European).
  • • PhD Summa Cum Laude in analytical chemistry.
  • • Director of the Biosensor project.
  • • PhD teacher in the department of chemistry.
  • • Analytic of the chemistry science of the BIOSENSOR UCM.
  • • 16 years of research activity: environmental and toxicological control, food analysis and detection of clinical interesting or pathogenic microorganism markers.
  • • Grant of the JUAN DE LA CIERVA Program at the Biological Research Center of the CSIC.
  • • Complutense University Master's Grant 2010-2011 - Department of Nanoengineering, University of California, San Diego.

MARÍA LAURA GARCÍA BERMEJO

  • • Bachelor in chemical sciences.
  • • PhD Summa Cum Laude in biological sciences.
  • • Project Manager Biomarkers and Therapeutic Targets – IRYCIS.
  • • Vice-president of the biomarker platform of the European infrastructure of translational medicine (EATRIS).
  • • Director of Area IV of IRYCIS (Epidemiology and Health Technologies).
  • • Number of funded research projects in which she has participated:
  • - Internationals: 10; as a researcher responsible for the group: 3
  • - Nationals: 30; as a researcher responsible for the group: 16
  • - Networks (RETICS): 3
  • - Projects / research contracts with pharmaceutical companies: 5
  • - Clinical Trials: 5

ANTONIO MONIS RUIZ

  • • Expert Financial and Strategic Advisor.
  • • Degree in Economic and Business Sciences, branch of Business by the Autonomous University of Madrid, (Specialty Financing).
  • • Master in Financial Management and Control (business institute, IE).
  • • Participation in international projects.
  • • Financial and Risk Ex-Director in ING Seguros.
  • • Independent adviser of REALE VIDA.
  • • President of Mirnax Biosens, S.L.

MARÍA INMACULADA CALVO SÁNCHEZ

  • • Doctorate in Celullar and Genetic Biology (Universidad Autónoma, Madrid).
  • • Doctor Professor at the Francisco de Vitoria University Foundation, Madrid.
  • • Active participation in 10 research projects.
  • • Author of 12 scientific articles.
  • • An international patent.
  • • Researcher associated to Derma Innovate, S.L.

JOAN MONTANER VILLALONGA

  • • Bachelor in Medicine and Surgery.
  • • Specialist in Neurology at the Vall d'Hebron University Hospital in Barcelona.
  • • Director of the Stroke Program, IBIS-VHIR, Seville.

GUSTAVO FÚSTER OLAGUIBEL

  • • Bachelor in Pharmacy from the Complutense University of Madrid.
  • • Bacherlor in Law from the National University of Distance Education (UNED).
  • • Master in Management and Administration of biotechnology companies by Aliter.
  • • European patent agent.
  • • Director of Hoffmann Eitle, S.L.U.

BONIFACIO NICOLÁS DÍAZ CHICO

  • • Director of the Title of University Expert in Molecular Oncology of the universities of Las Palmas de GC and La Laguna (Editions 2003 and 2004).
  • • Director of the Master's Degree in Molecular Oncology at the University of Las Palmas de Gran Canaria (Edition 2003-05).
  • • Chief Executive Officer of the technological institute of Canarias S.A., belonging to the government of the Canary Islands (2011-13).
  • • President of the Spanish Association for Research on Cancer (ASEICA, 2005-08).
  • • President of the Organizing Committee of the V and XI Congress of ASEICA (Las Palmas, 1993 and 2007).
  • • Professor of Physiology. University of Las Palmas de Gran Canaria (1992-present).